**US01881G1067**

We assign a fundamental rating of **5** out of 10 to **AB**. **AB** was compared to 200 industry peers in the **Capital Markets** industry. While **AB** has a great profitability rating, there are some concerns on its financial health. **AB** has a valuation in line with the averages, but on the other hand it scores bad on growth

The Piotroski-F score of **AB** is **4.00**. This is a neutral score and indicates average health and profitability for **AB**.

ROA (16.86%) VS Industry: 93% outperformed.

-898.87

49.12

ROE (21.38%) VS Industry: 76% outperformed.

0.04

291.37

Profit Margin (91.25%) VS Industry: 95% outperformed.

-59,330.17

84,632.11

The **Price/Earnings Ratio** is **11.40**, which indicates a very decent valuation of **AB**.

The low **PEG Ratio**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

With a **Forward Price/Earnings Ratio** of **13.97**, **AB** is valued correctly.

When comparing the current price to the book value of **AB**, we can conclude it is valued correctly. It is trading at **2.58** times its book value.

Compared to an average industry price book ratio of 1.20, **AB** is valued more expensive than its industry peers.

Price/Earnings (11.4) VS Industry: 44% outperformed.

247.53

0.89

Price/Book (2.58) VS Industry: 25% outperformed.

63.80

0.16

Based on estimates for the next 5 years, **AB** will show a decrease in **Earnings Per Share**. The EPS will decrease by **-7.29%** on average per year.

Looking at the last year, **AB** shows a decrease in **Revenue**. The Revenue has decreased by **-4.16%** in the last year.

Based on estimates for the next 5 years, **AB** will show a small growth in **Revenue**. The Revenue will grow by **1.68%** on average per year.

When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | 15.23% | 13.32% | -1.12% | -23.93% | -13.93% | -9.85% | -7.29% |

Revenue | 11.7% | 15.44% | -4.16% | -10.54% | -2.56% | 1.81% | 1.68% |

The Debt to Equity ratio of **AB** is way better than the industry averages.

The Piotroski-F score of **AB** is **4.00**. This is a neutral score and indicates average health and profitability for **AB**.

Debt/Equity (0) VS Industry: 80% outperformed.

8.26

0.00

Compared to an average industry **Dividend Yield** of **5.06**, **AB** pays a better dividend. On top of this **AB** pays more dividend than 86% of the companies listed in the same industry.

Compared to an average S&P500 **Dividend Yield** of **2.47**, **AB** pays a better dividend.

On average, the dividend of **AB** grows each year by **7.52%**, which is quite nice.

Dividend Yield (11.24%) VS Industry: 86% outperformed.

0.03

168.27

NYSE:AB (11/30/2022, 7:17:13 PM)**-0.01 (-0.02%) **

GICS Sector | Financials | ||

GICS IndustryGroup | Diversified Financials | ||

GICS Industry | Capital Markets | ||

Earnings (Last) | 10-28 2022-10-28/bmo | Earnings (Next) | 02-09 2023-02-09 |

Ins Owners | 0.48% | Inst Owners | 11.33% |

Market Cap | 4.06B | Analysts | 77.14 |

PE | 11.4 | Fwd PE | 13.97 |

PEG (NY) | N/A | PEG (5Y) | 0.75 |

P/S | 11.03 | P/B | 2.58 |

EV/EBITDA | N/A |

Dividend Yield | 11.24% | Dividend Growth | 7.52% |

DP | 112.22% | Ex-Date | 11-04 2022-11-04 (0.64) |

EPS 1Y | -1.12% | EPS 3Y | 13.32% |

EPS 5Y | 15.23% | EPS growth Q2Q | -28.09% |

EPS Next Y | -23.93% | EPS Next 2Y | -13.93% |

EPS Next 3Y | -9.85% | EPS Next 5Y | -7.29% |

Revenue growth 1Y | -4.16% | Revenue growth 3Y | 15.44% |

Revenue growth 5Y | 11.7% | Revenue growth Q2Q | -33.38% |

Revenue Next Year | -10.54% | Revenue Next 2Y | -2.56% |

Revenue Next 3Y | 1.81% | Revenue Next 5Y | 1.68% |

Current Ratio | N/A | Quick Ratio | N/A |

Altman-Z | N/A | F-Score | 4 |

Debt/Equity | 0 | WACC | N/A |

ROIC/WACC | N/A |

ROA | 16.86% | ROE | 21.38% |

ROICexgc | N/A | ROIC | N/A |

PM | 91.25% | OM | 100% |

Asset Turnover | 0.18 |

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*